March 2024 The first status conference for the Ozempic multidistrict litigation occurred last week, gathering attorneys from Novo Nordisk and plaintiffs who have either filed cases or are seeking positions in the plaintiffs attorney leadership group for the MDL
Johnston JL, et al
Starting with one from Endocrine Reviews from May 2024 by Hoong-Wei Gan, Manuela Cerbone, and Mehul Tulsidas Dattani, Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity , says Abel, provided a comprehensive overview of the complex interacting pathways by which the hypothalamus receives numerous peripheral hormonal signals from the gut and adipose tissue, such as leptin, ghrelin, glucagon-like peptide 1 (GLP1), and others and integrate these to regulate feeding behavior, energy expenditure, and body weight
At 178 pounds and about 19% body fat, I was carrying more fluff than I wanted but nowhere near what you would call overweight
Pharmacokinetics, safety, and tolerability of oral semaglutide in healthy Japanese and Caucasian subjects: A randomized, double-blind, placebo-controlled trial